Yu.N. Khlypovka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yu.N. Khlypovka has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Svetlana V. Nikolaeva
Central Research Institute of Epidemiology of the Federal Service on Customers’ Rights Protection and Human Well-Being Surveillance
6 shared publications - Aleksander V. Gorelov
Sechenov First Moscow State Medical University (Sechenov University)
5 shared publications Ю. Н. Хлыповка
ГБУЗ «Московский многопрофильный клинический центр «Коммунарка» Департамента здравоохранения города Москвы
5 shared publications- Denis Nikolaevich Protsenko
Pirogov Russian National Research Medical University
4 shared publications - Olga N. Solodovnikova
Moscow Multidisciplinary Clinical Center «Kommunarka
4 shared publications - A. A. Erovichenkov
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences; Russian Medical Academy of Postgraduate Education
3 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (6) , 109-115
Clinical and laboratory features of the course of measles in children
Purpose of the study. The analysis of the frequency of elevated liver enzymes in children with measles during the course of the disease. Materials and methods. We conducted an analysis and statistical processing of 523 medical histories of children aged from 2 months to 17 years, hospitalized with a diagnosis of «Measles» in the children’s infectious disease ward of MMCC «Kommunarka», for the period from January 2023 to March 2024. Results. Upon admission to the children’s infectious disease ward with a diagnosis of «Measles» biochemical blood analysis was performed on 521 children. We found that an increase in transaminases up to 5 times or more above normal was observed in 35 children, accounting for 6.7% of the total number of children. The highest number of children with elevated liver enzymes up to 5 or more times normal was among those aged 12 to 17 years — 21 children, which is 60%. However, this elevation was asymptomatic and did not affect the course or duration of the illness. Conclusion. Given the ongoing epidemic instability in the measles incidence, further monitoring of clinical and laboratory data will allow for the development of optimal clinical and diagnostic algorithms for managing patients with measles.
- 30 December 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (6) , 109-115
Open AccessClinical and laboratory features of the course of measles in children
Purpose of the study. The analysis of the frequency of elevated liver enzymes in children with measles during the course of the disease. Materials and methods. We conducted an analysis and statistical processing of 523 medical histories of children aged from 2 months to 17 years, hospitalized with a diagnosis of «Measles» in the children’s infectious disease ward of MMCC «Kommunarka», for the period from January 2023 to March 2024. Results. Upon admission to the children’s infectious disease ward with a diagnosis of «Measles» biochemical blood analysis was performed on 521 children. We found that an increase in transaminases up to 5 times or more above normal was observed in 35 children, accounting for 6.7% of the total number of children. The highest number of children with elevated liver enzymes up to 5 or more times normal was among those aged 12 to 17 years — 21 children, which is 60%. However, this elevation was asymptomatic and did not affect the course or duration of the illness. Conclusion. Given the ongoing epidemic instability in the measles incidence, further monitoring of clinical and laboratory data will allow for the development of optimal clinical and diagnostic algorithms for managing patients with measles.
- Open Access
- 24 September 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (3) , 19-25
Clinical and epidemiological characteristics of imported intestinal infections in children
Клинико-эпидемиологическая характеристика завозных кишечных инфекций у детей
- 24 September 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (3) , 19-25
Open AccessClinical and epidemiological characteristics of imported intestinal infections in children
Клинико-эпидемиологическая характеристика завозных кишечных инфекций у детей
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 13 (4)
Variations of streptococcal infection in children
Варианты стрептококковой инфекции у детей
- 1 January 2024
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 13 (4)
Open AccessVariations of streptococcal infection in children
Варианты стрептококковой инфекции у детей
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 13 (4)
Assessment of quality of life and adherence to treatment with Kagocel® in adult patients with acute respiratory viral infections in real clinical practice
Оценка качества жизни и приверженности лечению препаратом Кагоцел у взрослых пациентов с острой респираторной вирусной инфекцией в условиях реальной
- 1 January 2024
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 13 (4)
Open AccessAssessment of quality of life and adherence to treatment with Kagocel® in adult patients with acute respiratory viral infections in real clinical practice
Оценка качества жизни и приверженности лечению препаратом Кагоцел у взрослых пациентов с острой респираторной вирусной инфекцией в условиях реальной
- Open Access
- 27 June 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (2) , 12-17
Early warning system of clinical deterioration in pediatric patients with common cold
Раннее выявление риска клинического ухудшения у пациентов детского возраста при острых респираторных вирусных инфекциях
- 27 June 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (2) , 12-17
Open AccessEarly warning system of clinical deterioration in pediatric patients with common cold
Раннее выявление риска клинического ухудшения у пациентов детского возраста при острых респираторных вирусных инфекциях
- 7 April 2023
- Published by Open Systems Publications in Лечащий врач
- No. 4(26)
Differential diagnosis of acute respiratory infections in mixed circulation
Acute respiratory infections are the most common group of infectious diseases characterized by pronounced tropism to the respiratory tract. Acute respiratory infections has occupied a leading place in the structure of infectious and parasitic diseases for decades. The high prevalence of diseases, the presence of adverse outcomes and complications, the difficulty of diagnosis and the choice of an individual treatment strategy making relevant the problems of an associated with acute respiratory tract infections. The review article describes in detail the features of manifestations of acute respiratory infections of viral etiology, occupying up to 80% of all cases in the epidemic season (influenza, parainfluenza, adenoviruses, rhinoviruses, respiratory syntial virus, coronaviruses, metapneumovirus, bokavirus). The characteristics and severity of the course of acute respiratory tract infections of bacterial etiology (Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydophyla pneumoniae, Streptococcus pyogenes) are also presented. The features of various clinical manifestations of circulating respiratory infections are analyzed. The features of nosological forms in acute respiratory infections are presented. Risk factors for the unfavorable course of acute infections pathways to the respiratory tract were noted. Modern methods of laboratory diagnostics of acute respiratory infections are described, illustrated in a convenient algorithm. The necessity of early etiological verification of acute respiratory infections for the timely appointment of adequate therapy, which reduces the risk of severe course and complications, is also emphasized. Thus, the similarity of clinical manifestations of acute viral infections of the respiratory tract, especially with the simultaneous circulation of various respiratory viruses during the ongoing COVID-19 pandemic, requires mandatory laboratory verification of the pathogen for timely etiotropic therapy and prevention of the spread of infection, as well as timely anti-epidemic measures.
- 7 April 2023
- Published by Open Systems Publications in Лечащий врач
- No. 4(26)
Differential diagnosis of acute respiratory infections in mixed circulation
Acute respiratory infections are the most common group of infectious diseases characterized by pronounced tropism to the respiratory tract. Acute respiratory infections has occupied a leading place in the structure of infectious and parasitic diseases for decades. The high prevalence of diseases, the presence of adverse outcomes and complications, the difficulty of diagnosis and the choice of an individual treatment strategy making relevant the problems of an associated with acute respiratory tract infections. The review article describes in detail the features of manifestations of acute respiratory infections of viral etiology, occupying up to 80% of all cases in the epidemic season (influenza, parainfluenza, adenoviruses, rhinoviruses, respiratory syntial virus, coronaviruses, metapneumovirus, bokavirus). The characteristics and severity of the course of acute respiratory tract infections of bacterial etiology (Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydophyla pneumoniae, Streptococcus pyogenes) are also presented. The features of various clinical manifestations of circulating respiratory infections are analyzed. The features of nosological forms in acute respiratory infections are presented. Risk factors for the unfavorable course of acute infections pathways to the respiratory tract were noted. Modern methods of laboratory diagnostics of acute respiratory infections are described, illustrated in a convenient algorithm. The necessity of early etiological verification of acute respiratory infections for the timely appointment of adequate therapy, which reduces the risk of severe course and complications, is also emphasized. Thus, the similarity of clinical manifestations of acute viral infections of the respiratory tract, especially with the simultaneous circulation of various respiratory viruses during the ongoing COVID-19 pandemic, requires mandatory laboratory verification of the pathogen for timely etiotropic therapy and prevention of the spread of infection, as well as timely anti-epidemic measures.
- Open Access
- 12 November 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 19,p. 29-34-34
Features of the course of influenza and its co-infection in children at the present stage
Influenza is an acute respiratory infection, mainly affecting the respiratory tract (often the trachea), with a tendency to develop symptoms rapidly and in most cases not requiring hospitalization. All acute respiratory infections are non-specific, with symptoms of intoxication, catarrhal symptoms (nasal congestion, rhinorrhoea, sore throat or pharyngeal discomfort), fever and cough. Improvement and widespread implementation of molecular methods to identify respiratory pathogens has led to the establishment of a higher frequency of co-infections. A literature review of the frequency of influenza co-infections is presented. Clinical cases of monoinfluenza and co-infections of influenza and respiratory syncytial infection are described, demonstrating the antagonistic effect of the two viruses on the course of the disease. In the first case, the patient, 1 year 1 month old, was hospitalised with a fever of 39 ºC in a moderate condition. A nasopharyngeal swab showed RNA of influenza A virus by PCR and was diagnosed with influenza. In the second case, the patient, 2 years old, at the beginning of the disease complained of an increase in body temperature to 38.7 ºC, cough, and difficulty in nasal breathing. On admission, the patient was in moderate condition with a body temperature of 36.6 ºC, clear consciousness and well-being. On auscultation, breathing in the lungs was rigid, single moist rales, scattered on both sides. A nasopharyngeal swab showed RNA of influenza A virus and respiratory syncytial virus by PCR. A viral acute respiratory infection of combined etiology and acute bronchitis was diagnosed. In the third case, a 14-year-old patient presented with complaints of fever up to 39 ºC, headache, weakness, muscle pain, dry cough. The condition was of moderate severity. The diagnosis of influenza A was confirmed by a rapid test for influenza A/B/C. In the treatment and prevention of both monoinfection and co-infections of influenza and other viruses, these clinical examples demonstrate the effectiveness of oseltamivir. These clinical examples highlight some key parameters: respiratory co-infections change the typical clinical picture of the disease, making it difficult to clinically diagnose the infection, highlighting laboratory diagnosis, which in turn facilitates rapid verification of the diagnosis and timely prescription of adequate therapy.
- 12 November 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 19,p. 29-34-34
Open AccessFeatures of the course of influenza and its co-infection in children at the present stage
Influenza is an acute respiratory infection, mainly affecting the respiratory tract (often the trachea), with a tendency to develop symptoms rapidly and in most cases not requiring hospitalization. All acute respiratory infections are non-specific, with symptoms of intoxication, catarrhal symptoms (nasal congestion, rhinorrhoea, sore throat or pharyngeal discomfort), fever and cough. Improvement and widespread implementation of molecular methods to identify respiratory pathogens has led to the establishment of a higher frequency of co-infections. A literature review of the frequency of influenza co-infections is presented. Clinical cases of monoinfluenza and co-infections of influenza and respiratory syncytial infection are described, demonstrating the antagonistic effect of the two viruses on the course of the disease. In the first case, the patient, 1 year 1 month old, was hospitalised with a fever of 39 ºC in a moderate condition. A nasopharyngeal swab showed RNA of influenza A virus by PCR and was diagnosed with influenza. In the second case, the patient, 2 years old, at the beginning of the disease complained of an increase in body temperature to 38.7 ºC, cough, and difficulty in nasal breathing. On admission, the patient was in moderate condition with a body temperature of 36.6 ºC, clear consciousness and well-being. On auscultation, breathing in the lungs was rigid, single moist rales, scattered on both sides. A nasopharyngeal swab showed RNA of influenza A virus and respiratory syncytial virus by PCR. A viral acute respiratory infection of combined etiology and acute bronchitis was diagnosed. In the third case, a 14-year-old patient presented with complaints of fever up to 39 ºC, headache, weakness, muscle pain, dry cough. The condition was of moderate severity. The diagnosis of influenza A was confirmed by a rapid test for influenza A/B/C. In the treatment and prevention of both monoinfection and co-infections of influenza and other viruses, these clinical examples demonstrate the effectiveness of oseltamivir. These clinical examples highlight some key parameters: respiratory co-infections change the typical clinical picture of the disease, making it difficult to clinically diagnose the infection, highlighting laboratory diagnosis, which in turn facilitates rapid verification of the diagnosis and timely prescription of adequate therapy.
- Open Access
- 12 July 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 40-43
Acute respiratory infections of concomitant etiology in children
Acute respiratory infections (ARIs) still represent a considerable challenge in the infectious pathology patterns. ARIs are included in the list of diseases with the greatest economic importance in the Russian Federation. According to the State Report on Sanitary and Epidemiological Welfare of Population in the Russian Federation in 2020, ARIs hold a dominant position in the infectious and parasitic disease patterns. The issue of concomitant infection is extremely topical today. Three scenarios of interaction between respiratory causative pathogens may develop in co-infections: synergism (more severe progress of a disease as compared to mono-infections), antagonism (milder progress of an infectious disease) or indifference (absence of interaction between two infectious pathogens, as a result of which a disease develops as two separate infections). A clinical symptom presentation of a disease may be distorted, as new symptoms that are not typical of the traditional progression of each of the infections may appear. In clinical practice, antibacterial therapy is often prescribed in cases where etiological infectious agents are not identified, and a reference point is the clinical characteristics of a disease and the severity of patient's condition that is most frequently caused by intoxication symptoms and intensity of feverish reaction and is exhibiting similar symptoms in viral and bacterial ARIs. That is why the rapid identification of the causative agents can help avoid irrational therapy and polypragmasia. The article provides a clinical case of the treatment of ARI of concomitant etiology which required a differentiated approach and prescription of an antiviral drug.
- 12 July 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 40-43
Open AccessAcute respiratory infections of concomitant etiology in children
Acute respiratory infections (ARIs) still represent a considerable challenge in the infectious pathology patterns. ARIs are included in the list of diseases with the greatest economic importance in the Russian Federation. According to the State Report on Sanitary and Epidemiological Welfare of Population in the Russian Federation in 2020, ARIs hold a dominant position in the infectious and parasitic disease patterns. The issue of concomitant infection is extremely topical today. Three scenarios of interaction between respiratory causative pathogens may develop in co-infections: synergism (more severe progress of a disease as compared to mono-infections), antagonism (milder progress of an infectious disease) or indifference (absence of interaction between two infectious pathogens, as a result of which a disease develops as two separate infections). A clinical symptom presentation of a disease may be distorted, as new symptoms that are not typical of the traditional progression of each of the infections may appear. In clinical practice, antibacterial therapy is often prescribed in cases where etiological infectious agents are not identified, and a reference point is the clinical characteristics of a disease and the severity of patient's condition that is most frequently caused by intoxication symptoms and intensity of feverish reaction and is exhibiting similar symptoms in viral and bacterial ARIs. That is why the rapid identification of the causative agents can help avoid irrational therapy and polypragmasia. The article provides a clinical case of the treatment of ARI of concomitant etiology which required a differentiated approach and prescription of an antiviral drug.
- 16 December 2021
- Published by Alfmed LLC in Medical alphabet
- No. 32,p. 7-9
Features of influenza’s course in combination with other viruses in children
The objective. To evaluate the frequency and laboratory characteristics of pneumonia in children when influenza is combined with other respiratory viruses.Materials and methods. We examined 72 children aged 1 month to 17 years who were hospitalized in a specialized hospital in 2017–2019 with influenza type A (72 %) or B (28 %). The main group included 36 patients who had a laboratory-confirmed combination of influenza with other respiratory viruses, and the comparison group included 36 cases in which influenza was the only pathogen detected.Results. The analysis of the frequency of complications showed that in the main group, pneumonia developed significantly more often – in 22 % (8 children), and in the comparison group – in 6 % (2 children, p < 0.05).Conclusions. 1) The combination of influenza with other respiratory viruses is a risk factor for the development of pneumonia in children. 2) There are no significant changes in the indicators of clinical blood analysis in pneumonia developing against the background of influenza, including in combination with other respiratory viruses.
- 16 December 2021
- Published by Alfmed LLC in Medical alphabet
- No. 32,p. 7-9
Features of influenza’s course in combination with other viruses in children
The objective. To evaluate the frequency and laboratory characteristics of pneumonia in children when influenza is combined with other respiratory viruses.Materials and methods. We examined 72 children aged 1 month to 17 years who were hospitalized in a specialized hospital in 2017–2019 with influenza type A (72 %) or B (28 %). The main group included 36 patients who had a laboratory-confirmed combination of influenza with other respiratory viruses, and the comparison group included 36 cases in which influenza was the only pathogen detected.Results. The analysis of the frequency of complications showed that in the main group, pneumonia developed significantly more often – in 22 % (8 children), and in the comparison group – in 6 % (2 children, p < 0.05).Conclusions. 1) The combination of influenza with other respiratory viruses is a risk factor for the development of pneumonia in children. 2) There are no significant changes in the indicators of clinical blood analysis in pneumonia developing against the background of influenza, including in combination with other respiratory viruses.
- Open Access
- 21 March 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 78-82
Respiratory infections of combined etiology in the clinical practice of the pediatrician
Acute respiratory infections hold the leading position in the structure of infectious pathology in children and are one of the main reasons for visits to the doctor. Most often causative agents of acute respiratory infections are viruses. In recent years, respiratory infections of combined etiology are becoming an increasingly significant problem, the proportion of which is increasing.In co-infections, clinical diagnosis is difficult, which once again emphasizes the importance of the widespread introduction of highly sensitive etiological diagnostic methods, in particular polymerase chain reaction. Data on the tendency to a more severe course of co-infections compared to mono-infections are ambiguous, which seems to depend on the specific causative agent and the level of viral load. Another urgent problem of acute respiratory infections in children is the frequent registration of concomitant respiratory viral and herpes virus infections. The clinical picture of acute respiratory tract infections is not very diverse: fever, intoxication symptoms, cough, nasal congestion, rhinorrhea, sore throat, etc. At the same time, pathognomonic symptoms can be identified in some monoinfections, but in coinfections such clinical diagnosis is difficult, suggesting the importance of etiological diagnosis, especially polymerase chain reaction (PCR).All of the above, as well as age and clinical manifestations largely determine the rational selection of antiviral therapy simultaneously effective against both respiratory viruses and herpes viruses. One such drug is Cycloferon, which has not only a broad antiviral spectrum, but also a high level of safety.Inclusion of an interferon inducer in the treatment of acute respiratory infections will reduce the need to prescribe other drugs, including antibiotics, and reduce the medication load on the body.
- 21 March 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 78-82
Open AccessRespiratory infections of combined etiology in the clinical practice of the pediatrician
Acute respiratory infections hold the leading position in the structure of infectious pathology in children and are one of the main reasons for visits to the doctor. Most often causative agents of acute respiratory infections are viruses. In recent years, respiratory infections of combined etiology are becoming an increasingly significant problem, the proportion of which is increasing.In co-infections, clinical diagnosis is difficult, which once again emphasizes the importance of the widespread introduction of highly sensitive etiological diagnostic methods, in particular polymerase chain reaction. Data on the tendency to a more severe course of co-infections compared to mono-infections are ambiguous, which seems to depend on the specific causative agent and the level of viral load. Another urgent problem of acute respiratory infections in children is the frequent registration of concomitant respiratory viral and herpes virus infections. The clinical picture of acute respiratory tract infections is not very diverse: fever, intoxication symptoms, cough, nasal congestion, rhinorrhea, sore throat, etc. At the same time, pathognomonic symptoms can be identified in some monoinfections, but in coinfections such clinical diagnosis is difficult, suggesting the importance of etiological diagnosis, especially polymerase chain reaction (PCR).All of the above, as well as age and clinical manifestations largely determine the rational selection of antiviral therapy simultaneously effective against both respiratory viruses and herpes viruses. One such drug is Cycloferon, which has not only a broad antiviral spectrum, but also a high level of safety.Inclusion of an interferon inducer in the treatment of acute respiratory infections will reduce the need to prescribe other drugs, including antibiotics, and reduce the medication load on the body.